LAG3 antibody (AA 1-360)
LAG3
Reactivity: Human
WB
Host: Rabbit
Polyclonal
unconjugated
-
-
Target
See all LAG3 Antibodies
-
LAG3
(Lymphocyte-Activation Gene 3 (LAG3))
-
Binding Specificity
-
AA 1-360
-
Reactivity
-
Human
-
Host
-
Rabbit
-
Clonality
-
Polyclonal
-
Conjugate
-
This LAG3 antibody is un-conjugated
-
Application
-
Western Blotting (WB)
-
Purpose
-
Rabbit polyclonal antibody raised against a full-length human LAG3 protein.
-
Sequence
-
MWEAQFLGLL FLQPLWVAPV KPLQPGAEVP VVWAQEGAPA QLPCSPTIPL QDLSLLRRAG VTWQHQPDSG PPAAAPGHPL APGPHPAAPS SWGPRPRRYT VLSVGPGGLR SGRLPLQPRV QLDERGRQRG DFSLWLRPAR RADAGEYRAA VHLRDRALSC RLRLRLGQAS MTASPPGSLR ASDWVILNCS FSRPDRPASV HWFRNRGQGR VPVRESPHHH LAESFLFLPQ VSPMDSGPWG CILTYRDGFN VSIMYNLTVL GLEPPTPLTV YAGAGSRVGL PCRLPAGVGT RSFLTAKWTP PGGGPDLLVT GDNGDFTLRL EDVSQAQAGT YTCHIHLQEQ QLNATVTLAI ITGQPQVGKE
-
Cross-Reactivity
-
Human
-
Characteristics
-
Antibody reactive against mammalian transfected lysate.
-
Immunogen
-
LAG3 (AAH52589.1, 1 a.a. ~ 360 a.a) full-length human protein.
-
Top Product
-
Discover our top product LAG3 Primary Antibody
-
-
-
Application Notes
-
Optimal working dilution should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Buffer
-
In 1x PBS, pH 7.4
-
Handling Advice
-
Aliquot to avoid repeated freezing and thawing.
-
Storage
-
-20 °C
-
Storage Comment
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Quach, Metz, Thomas, Rothbard, Steinman, Ousman: "CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients." in: Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 19, Issue 14, pp. 1867-77, (2013) (PubMed).
-
-
Target
-
LAG3
(Lymphocyte-Activation Gene 3 (LAG3))
-
Alternative Name
-
LAG3 (LAG3 Products)
-
Synonyms
-
CD223 antibody, LAG-3 antibody, Ly66 antibody, lymphocyte activating 3 antibody, lymphocyte-activation gene 3 antibody, LAG3 antibody, Lag3 antibody
-
Background
-
Full Gene Name: lymphocyte-activation gene 3
Synonyms: CD223
-
Gene ID
-
3902
-
Pathways
-
Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-